Companies / Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp
Financials · FY2025
Ownership
159.6M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 3.31% | 5,284,951 |
| 10%+ / strategic | 7.51% | 11,992,448 |
| Institutions | 86.16% | 137,511,742 |
| Public float | 3.01% | 4,806,701 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Robins Chad MCEOCEO and Chairman · Director | 1.44% | 2,301,113 |
Robins Harlan SChief Scientific Officer | 0.95% | 1,522,058 |
Rubinstein JuliePresident and COO | 0.29% | 455,878 |
Bobulsky SusanChief Commercial Officer, MRD | 0.27% | 427,775 |
Lo FrancisFormerChief People Officer | 0.18% | 291,374 |
Benzeno SharonFormerChief Commercial Ofc Imm Med | 0.17% | 272,751 |
Piskel KyleChief Financial Officer | 0.16% | 259,840 |
Neupert Peter MDirector | 0.15% | 240,315 |
Owen Katey EinterzFormerDirector | 0.06% | 88,254 |
Hershberg RobertDirector | 0.04% | 62,347 |
Institutional holders 295
View all →| Holder | Value | % of shares |
|---|---|---|
| $416.31M | 18.79% | |
| $324.73M | 9.49% | |
| $183.22M | 7.07% | |
| $75.46M | 3.41% | |
| $74.18M | 2.17% | |
| $50.48M | 2.28% | |
| $50.47M | 1.95% | |
| $47.13M | 1.82% | |
| $44.83M | 1.73% | |
| $43.44M | 1.68% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Robins Chad M CEO | Sell | Common Stock | $4.57M | -289K -12.70% | 1,987,330 1.25% of shares | medium |
| Mar 11, 2026 | Robins Harlan S Executive | Sell | Common Stock | $4.34M | -330K -17.80% | 1,522,058 0.95% of shares | medium |
| Mar 11, 2026 | Robins Chad M CEO | Sell | Common Stock | $4.34M | -330K -12.53% | 2,301,113 1.44% of shares | medium |
| Feb 27, 2026 | Robins Chad M CEO | Sell | Common Stock | $2.92M | -183K -7.44% | 2,276,354 1.43% of shares | medium |
| Feb 2, 2026 | Robins Chad M CEO | Sell | Common Stock | $2.30M | -125K -4.84% | 2,459,245 1.54% of shares | medium |
| Jan 5, 2026 | Robins Chad M CEO | Sell | Common Stock | $1.95M | -125K -4.61% | 2,584,243 1.62% of shares | medium |
| Mar 11, 2026 | Robins Harlan S Executive | Sell | Common Stock | $1.85M | -141K -7.06% | 1,851,658 1.16% of shares | medium |
| Mar 11, 2026 | Robins Chad M CEO | Sell | Common Stock | $1.85M | -141K -5.07% | 2,630,713 1.65% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| BlackRock, Inc. | Passive13G/A | — |
| Viking Global Investors LP | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ADPT | — | 00650F109 |